DHRS2 and stage 5 chronic kidney disease: In our earlier studies, we found that patients with secondary immunodeficiency states due to hematological malignancies and end-stage renal disease had decreased serum antibody levels to protein D, one of the well-characterized protective NTHi antigens included in a pediatric vaccine Synflorix [52].